Hey, Hoops!
I've sort of run thru a simple analysis of
Hey, Hoops!
I've sort of run thru a simple analysis of GNBT shares as they relate to NGIO shares a couple of times, and here's my thinking.
1) IF NGIO can get uplisted above $4/sh with 400MM shares (I still don't quite understand why it wasn't 200MM shares, even if we then ended up at $8/sh... but that's a different discussion), that implies a value of $1.6B for NGIO.
2) Let's presume GNBT ends up at 100MM shares OS after paying the bills post-NGIO spin.
3) GNBT keeps 70% of NGIO shares or 280MM shares.
4) This means that each share of GNBT would effectively "own" 2.8 shares of NGIO. That is $11.20 worth of a measurable, liquid asset.
5) So IF the market sees enough value to keep the NGIO shares at or above $4, I fail to see how GNBT shares would remain below $5 and not uplist... unless the market somehow thinks the GNBT assets have a hugely NEGATIVE value.
All that said, I still have a hard time seeing how there is somehow $1.56B ($1.6B less our current GNBT market cap) in value that will be unlocked simply by spinning off NGIO and listing on a major exchange. I've asked the board this Q before. Is simply allowing institutional buyers to participate all it takes to perform that magical release of pent-up value?
Otherwise, someone could come in now and buy GNBT shares to make a killing (as we're all hoping to do).
Currently, if we say GNBT assets are worth $0, the value of a share of NGIO is valued as follows:
1) ~80MM shares of GNBT own ~360MM shares of NGIO (rounding to 90%... I think it's closer to 91%). So each share of GNBT currently "owns" 4.5 shares of NGIO.
2) GNBT share price is $0.52. So $0.52/4.5 = an implied value of $0.1156/sh for NGIO.
3) If you apply a part of the $0.52 to GNBT assets, the implied value of each NGIO share only gets lower.
As I've said before, I think it is a HUGE stretch to fathom how an asset that is currently valued at about a dime is somehow worth $4+ when the uplist happens. And yet here I sit holding... and hoping... which I know is a terrible investment strategy.
Anyone else have insight/wisdom?
1
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...
Continue Reading
Breaking New Ground in Golf and Luxury Cabot and the Bragg family are cooking up something extraordinary in Cumberland County, Nova Scotia. The new luxury lifestyle and golf destination, Cabot Wilds, promises to be more than just a retreat—it's a bold statement on how to marry nature, luxury, and community. Set to open in late 2027, this expansive 2,500-acre resort will...
Continue Reading
A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...
Continue Reading
Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...
Continue Reading
Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...
Continue Reading
Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...
Continue Reading
Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...
Continue Reading
Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....
Continue Reading
Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...
Continue Reading
Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...
Continue Reading
Top 5 Most Recently Viewed Articles
Kristian Flaten Appointed as Chief Financial Officer at IDEX Biometrics IDEX Biometrics has made a significant addition to its executive team by appointing Kristian Flaten as Chief Financial Officer. Flaten’s expertise is expected to play a crucial role in steering the company through its pivotal growth stages. A Wealth of Experience in Financial Leadership With more...
Continue Reading
Exciting Developments in GLOPERBA® Dosing Adjustments In a recent milestone for pain management, Scilex Holding Company (Nasdaq: SCLX) has published findings on GLOPERBA® dosing adjustments in a peer-reviewed journal. GLOPERBA® stands out as the first liquid oral version of colchicine, a medication widely used for gout treatment. This innovative formulation is...
Continue Reading
Cheesecake Factory Reports Impressive Quarterly Results The restaurant sector is buzzing with excitement as Cheesecake Factory Inc (NASDAQ: CAKE) recently disclosed noteworthy financial outcomes for its latest quarter. Investors are taking notice of the company's enhanced revenue and strategic growth initiatives. Quarterly Financial Overview In a significant development,...
Continue Reading
Overview of Public Trading Disclosure FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Key Highlights The recent disclosures outline the trading activities involving Dowlais Group plc and highlight the role of Investec Bank plc as the exempt principal trader. Providing...
Continue Reading
CROSSJECT's Growing Collaboration with ETON PHARMACEUTICALS CROSSJECT is excited to announce an enhancement in its partnership with ETON PHARMACEUTICALS, Inc. This collaboration revolves around the groundbreaking hydrocortisone formulation, aimed at entering the hospital adrenal insufficiency market. By working together, CROSSJECT has positioned itself to earn a...
Continue Reading